Innovations in one-step point-of-care testing within microfluidics and lateral flow assays for shaping the future of healthcare
Biosensors and Bioelectronics · 2025-01 · 267 · 116795
DOI: 10.1016/j.bios.2024.116795 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors and Bioelectronics, 2025-01. Verfasst von Dan Strohmaier-Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, 93053, Regensburg, Germany. Hauptthemen laut MEDLINE: Point-of-Care Testing, Biosensing Techniques. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Universität Stuttgart.
Abstract (Originalsprache)
Point-of-care testing (POCT) technology, using lateral flow assays and microfluidic systems, facilitates cost-effective diagnosis, timely treatment, ongoing monitoring, and prevention of life-threatening outcomes. Aside from significant advancements demonstrated in academic research, implementation in real-world applications remains frustratingly limited. The divergence between academic developments and practical utility is often due to factors such as operational complexity, low sensitivity and the need for trained personnel. Taking this into consideration, our objective is to present a critical and objective overview of the latest advancements in fully integrated one-step POCT assays for home-testing which would be commercially viable. In particular, aspects of signal amplification, assay design modification, and sample preparation are critically evaluated and their features and medical applications along with future perspective and challenges with respect to minimal user intervention are summarized. Associated with and very important for the one-step POCT realization are also readout devices and fabrication processes. Critical analysis of available and useful technologies are presented in the SI section.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, 93053, Regensburg, Germany.
- Roche Diagnostics GmbH, 68305, Mannheim, Germany.
- Institute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, 93053, Regensburg, Germany. Electronic address: antje.baeumner@ur.de.
Förderung
- Universität Stuttgart
Zitieren
APA
Strohmaier-Nguyen, D., Horn, C., & Baeumner, A. J. (2025). Innovations in one-step point-of-care testing within microfluidics and lateral flow assays for shaping the future of healthcare. Biosensors and Bioelectronics, 267, 116795. https://doi.org/10.1016/j.bios.2024.116795
Vancouver
Strohmaier-Nguyen D, Horn C, Baeumner AJ. Innovations in one-step point-of-care testing within microfluidics and lateral flow assays for shaping the future of healthcare. Biosensors and Bioelectronics. 2025;267:116795. doi:10.1016/j.bios.2024.116795
BibTeX
@article{StrohmaierNguyen2025,
author = {Strohmaier-Nguyen, Dan and Horn, Carina and Baeumner, Antje J},
title = {Innovations in one-step point-of-care testing within microfluidics and lateral flow assays for shaping the future of healthcare},
journal = {Biosensors and Bioelectronics},
year = {2025},
volume = {267},
pages = {116795},
doi = {10.1016/j.bios.2024.116795}
}
EUVIMED